Lessons we Learned from High-Throughput and Top-Down Systems Biology Analyses about Glioma Stem Cells

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|20|1|66-72

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.1, 2014-01, pp. : 66-72

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lessons from high-throughput protein crystallization screening: 10 years of practical experience

By Luft Joseph R   Snell Edward H   DeTitta George T  

Expert Opinion on Drug Discovery, Vol. 6, Iss. 5, 2011-05 ,pp. : 465-480

Informa Healthcare

Access to resources Recommend Favorite

High-Throughput Structural Biology in Drug Discovery: Protein Kinases

By  

Current Pharmaceutical Design, Vol. 10, Iss. 10, 2004-04 ,pp. : 1069-1082

Bentham Science Publishers

Access to resources Recommend Favorite

Detection of Cancer Stem Cells from the C6 Glioma Cell Line

By Zhou X-D   Wang X-Y   Qu F-J   Zhong Y-H   Lu X-D   Zhao P   Wang D-H   Huang Q-B   Zhang L   Li X-G  

The Journal of International Medical Research, Vol. 37, Iss. 2, 2009-03 ,pp. : 503-510

Field House Publishing

Access to resources Recommend Favorite

Patent strategies for high-throughput screening systems: recent progress and future developments

By Jakobsen P.   Kurtzhals P.   Poulsen F.  

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 9, 1998-09 ,pp. : 1157-1165

Informa Healthcare

Access to resources Recommend Favorite

Regulation and Function of FoxO Transcription Factors in Normal and Cancer Stem Cells: What Have We Learned?

By  

Current Drug Targets, Vol. 12, Iss. 9, 2011-08 ,pp. : 1267-1283

Bentham Science Publishers

Access to resources Recommend Favorite